Olympus Biotech offering CMO services for biologics; Almac expands U.K. packaging capacity;

> The FDA has recalled an undisclosed number of lots of the steroid methylprednisolone acetate produced by an undisclosed compounding pharmacy because it is linked to a meningitis outbreak that has infected 14, killing two of them. Story

> Contract services company Almac says it has expanded the packaging capacity at its facility in the U.K. with a new blister packaging line. Release

> Alere says it has worked out with the FDA manufacturing issues for the manufacture of its blood-testing meters for testing heart attacks and will work to bring production up to demand. Story

> Sanofi announced Tuesday that it is buying Genfar, which it termed the second-largest generics maker in Colombia. Story

> Olympus Biotech has begun offering contract manufacturing offering (CMO) at its biologics facility in Lebanon, NH. Release

> A U.S. Senate bill that would impose criminal penalties on companies found price-gouging drugs that are on shortage lists has moved to a committee for consideration. Item

And Finally... Spanish API maker Medichem is letting the world know that its API plant in Girona has passed an FDA inspection for the fifth time in a row and didn't get any 483 write-ups. Release

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.